Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAMPION: Anesthesia for DBS in Parkinson's Disease
NCT05550714Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2022
- Primary completion
- Mar 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised, single-blind trial of desflurane in Parkinson's disease (PD) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Proportion of high-normalized root mean square recorded by the MER signal at 1 day. Started Oct 2022; status: recruiting.
02
Drugs
desflurane
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05550714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05550714.